{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:40:11Z","timestamp":1788982811696,"version":"build-2803163510"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108801","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T14:56:41Z","timestamp":1753541801000},"page":"108801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Bufadienolides as bioorganic anticancer agents: Mechanistic insights into apoptosis, cell cycle arrest and signal pathway modulation"],"prefix":"10.1016","volume":"164","author":[{"given":"Hector","family":"Hern\u00e1ndez-Parra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Ira\u00eds","family":"Pe\u00f1a-Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Isaac","family":"Ch\u00e1vez-Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Duarte-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Leyva-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab M.","family":"Almarhoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Klimek-Szczykutowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Kubica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Szopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Calina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108801_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010051","article-title":"Novel strategies for solubility and bioavailability enhancement of Bufadienolides","volume":"27","author":"Shao","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108801_bb0460","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4103\/0019-509X.200658","article-title":"Cancer and cure: a critical analysis","volume":"53","author":"Roy","year":"2016","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108801_bb0530","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global Cancer Incidence and Mortality Rates and Trends--An Update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.bioorg.2025.108801_bb0480","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.108801_bb0605","doi-asserted-by":"crossref","first-page":"1137547","DOI":"10.3389\/fchem.2023.1137547","article-title":"Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: current status and future directions","volume":"11","author":"Ye","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2025.108801_bb0680","article-title":"Resibufogenin: An emerging therapeutic compound with multifaceted pharmacological effects - a comprehensive review","volume":"30","author":"Zhang","year":"2024","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bioorg.2025.108801_bb0395","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1039\/C6NP00107F","article-title":"The synthesis of cardenolide and bufadienolide aglycones, and related steroids bearing a heterocyclic subunit","volume":"34","author":"Michalak","year":"2017","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0240","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s11101-017-9525-1","article-title":"Bufadienolides of Kalanchoe species: an overview of chemical structure, biological activity and prospects for pharmacological use","volume":"16","author":"Kolodziejczyk-Czepas","year":"2017","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.bioorg.2025.108801_bb0225","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1021\/jm0202066","article-title":"QSAR evaluation of the ch\u2019an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC\/PRF\/5(1)","volume":"45","author":"Kamano","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108801_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112178","article-title":"Metabolites from Bufo gargarizans (cantor, 1842): a review of traditional uses, pharmacological activity, toxicity and quality control","volume":"246","author":"Zhan","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100060","article-title":"Toad venom: a comprehensive review of chemical constituents, anticancer activities, and mechanisms","volume":"354","author":"Li","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.108801_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100060","article-title":"Toad venom: a comprehensive review of chemical constituents, anticancer activities, and mechanisms","volume":"354","author":"Li","year":"2021","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.108801_bb0310","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12935-021-02137-x","article-title":"Bufalin induces mitochondrial dysfunction and promotes apoptosis of glioma cells by regulating Annexin A2 and DRP1 protein expression","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioorg.2025.108801_bb0720","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002780R","article-title":"Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway","volume":"35","author":"Zou","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2025.108801_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173379","article-title":"Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment","volume":"887","author":"Deng","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/toxins16030159","article-title":"Comprehensive analysis of Bufadienolide and protein profiles of gland secretions from medicinal","volume":"16","author":"Fang","year":"2024","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bioorg.2025.108801_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1014637","article-title":"A research update on the antitumor effects of active components of Chinese medicine ChanSu","volume":"12","author":"Jia","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196586","article-title":"Chemistry and the potential antiviral, anticancer, and anti-inflammatory activities of Cardiotonic steroids derived from toads","volume":"27","author":"El-Seedi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108801_bb0140","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1039\/c0np00032a","article-title":"Bufadienolides and their antitumor activity","volume":"28","author":"Gao","year":"2011","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0415","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1021\/np0101088","article-title":"Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch\u2019an Su","volume":"64","author":"Nogawa","year":"2001","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.108801_bb0405","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/np400034d","article-title":"Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells","volume":"76","author":"Moreno","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.108801_bb0340","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.fitote.2019.03.006","article-title":"Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom","volume":"134","author":"Liu","year":"2019","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2025.108801_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127715","article-title":"Three bufadienolides induce cell death in the human lung cancer cell line CL1-5 mainly through autophagy","volume":"31","author":"Huang","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108801_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112038","article-title":"Total synthesis, chemical modification and structure-activity relationship of bufadienolides","volume":"189","author":"Zhong","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108801_bb0055","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.intimp.2003.08.004","article-title":"Apoptosis-mediated selective killing of malignant cells by cardiac steroids: maintenance of cytotoxicity and loss of cardiac activity of chemically modified derivatives","volume":"3","author":"Daniel","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0365","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.toxlet.2017.12.018","article-title":"Marinobufagin, a molecule from poisonous frogs, causes biochemical, morphological and cell cycle changes in human neoplasms and vegetal cells","volume":"285","author":"Machado","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bioorg.2025.108801_bb0435","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0022-4731(72)90006-4","article-title":"Biosynthesis of bufadienolides in toads. 3. Experiments with (2\u201314 C)mevalonic acid, (20\u201314 C)3 -hydroxy-5-pregnen-20-one and (20\u201314 C)cholesterol","volume":"3","author":"Porto","year":"1972","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bioorg.2025.108801_bb0490","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2017.01.004","article-title":"Bufadienolides from amphibians: a promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na","volume":"127","author":"Sousa","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.bioorg.2025.108801_bb0280","article-title":"Transcriptome analysis and identification of the cholesterol side chain cleavage enzyme BbgCYP11A1 from","volume":"13","author":"Li","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bioorg.2025.108801_bb0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.52711\/2321-5836.2023.00007","article-title":"The pharmacological activities of mother of thousand (Kalanchoe pinnata)","volume":"15","author":"Kumar","year":"2023","journal-title":"Res. J. Pharmacol. Pharmacodynam."},{"key":"10.1016\/j.bioorg.2025.108801_bb0495","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1039\/a815397y","article-title":"Bufadienolides of plant and animal origin","volume":"15","author":"Steyn","year":"1998","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0505","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1271\/bbb.64.1310","article-title":"New insecticidal bufadienolide, bryophyllin C, from Kalanchoe pinnata","volume":"64","author":"Supratman","year":"2000","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bioorg.2025.108801_bb0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.freeradbiomed.2019.08.015","article-title":"Kalantuboside B induced apoptosis and cytoprotective autophagy in human melanoma A2058\u00a0cells: An in vitro and in vivo study","volume":"143","author":"Hseu","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2025.108801_bb0130","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1055\/s-0042-106727","article-title":"Bryophyllum pinnatum and related species used in Anthroposophic medicine: constituents, pharmacological activities, and clinical efficacy","volume":"82","author":"F\u00fcrer","year":"2016","journal-title":"Planta Med."},{"key":"10.1016\/j.bioorg.2025.108801_bb0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clinbiochem.2004.08.005","article-title":"A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure","volume":"38","author":"Komiyama","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bioorg.2025.108801_bb0205","first-page":"15","article-title":"Antimicrobial compounds from skin secretions of species that belong to the Bufonidae Family","author":"Ibarra-Vega","year":"2023","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bioorg.2025.108801_bb0290","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.bcp.2012.01.023","article-title":"Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway","volume":"83","author":"Li","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0660","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/carcin\/bgt060","article-title":"Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K\/Akt\/mTOR pathway","volume":"34","author":"Zhang","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bioorg.2025.108801_bb0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ddr.22072","article-title":"Toad venom bufadienolides and bufotoxins: An updated review","volume":"84","author":"Asrorov","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2025.108801_bb0085","doi-asserted-by":"crossref","first-page":"11627","DOI":"10.18632\/oncotarget.3435","article-title":"\u03a8-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108801_bb0515","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/9789811405112120040005","article-title":"Recovery and purification of (bio) pharmaceuticals using (Nano) materials","volume":"4","author":"Tavares","year":"2020","journal-title":"Recent Adv. Anal. Tech."},{"key":"10.1016\/j.bioorg.2025.108801_bb0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.toxicon.2005.01.017","article-title":"Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescens","volume":"45","author":"Cunha Filho","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.bioorg.2025.108801_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2013.06.009","article-title":"Antiproliferative activity of Rhinella marina and Rhaebo guttatus venom extracts from southern Amazon","volume":"72","author":"Ferreira","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bioorg.2025.108801_bb0285","first-page":"2347","article-title":"Bufadienolides induce apoptosis and autophagy by inhibiting the AKT signaling pathway in melanoma A-375 cells","volume":"20","author":"Li","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.fitote.2017.06.022","article-title":"In vitro phase I metabolism of gamabufotalin and arenobufagin: reveal the effect of substituent group on metabolic stability","volume":"121","author":"Feng","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2025.108801_bb0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jpba.2011.05.014","article-title":"Comprehensive chemical analysis of Venenum Bufonis by using liquid chromatography\/electrospray ionization tandem mass spectrometry","volume":"56","author":"Hu","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2025.108801_bb0565","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jep.2019.03.042","article-title":"Venenum bufonis: An overview of its traditional use, natural product chemistry, pharmacology, pharmacokinetics and toxicology","volume":"237","author":"Wei","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0570","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.intimp.2015.02.005","article-title":"Telocinobufagin enhances the Th1 immune response and protects against salmonella typhimurium infection","volume":"25","author":"Wu","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0325","first-page":"734","article-title":"Pharmacokinetic study on bufadienolides of bufalin, cinobufagin, and resibufogenin from Bufonis Venenum in rats in vivo","volume":"43","author":"Liu","year":"2012","journal-title":"Chin. Tradit. Herb. Drug"},{"key":"10.1016\/j.bioorg.2025.108801_bb0320","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jpba.2007.11.001","article-title":"Simultaneous determination and pharmacokinetics of five bufadienolides in rat plasma after oral administration of Chansu extract by SPE-HPLC method","volume":"46","author":"Liang","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2025.108801_bb0230","first-page":"20","article-title":"Bufadienolides and their medicinal utility: a review","volume":"5","author":"Kamboj","year":"2013","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.bioorg.2025.108801_bb0330","first-page":"1256","article-title":"Determination of apparent aqueous solubility and apparent oil-water partition coefficients of three bufadienolides composition","volume":"33","author":"Liu","year":"2008","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.bioorg.2025.108801_bb0350","article-title":"Strategies for solubility and bioavailability enhancement and toxicity reduction of Norcantharidin","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108801_bb0700","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1479-5876-12-57","article-title":"Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice","volume":"12","author":"Zhang","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2025.108801_bb0675","doi-asserted-by":"crossref","first-page":"63311","DOI":"10.18632\/oncotarget.18800","article-title":"Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.108801_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106442","article-title":"Bufalin for an innovative therapeutic approach against cancer","volume":"184","author":"Soumoy","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2025.108801_bb0355","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijpharm.2016.04.041","article-title":"Polymeric prodrug of bufalin for increasing solubility and stability: synthesis and anticancer study in vitro and in vivo","volume":"506","author":"Liu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.108801_bb0475","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.colsurfb.2018.03.024","article-title":"Increasing the anticancer performance of bufalin (BUF) by introducing an endosome-escaping polymer and tumor-targeting peptide in the design of a polymeric prodrug","volume":"166","author":"Shi","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioorg.2025.108801_bb0715","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.msec.2017.04.094","article-title":"Folate receptor targeted bufalin\/\u03b2-cyclodextrin supramolecular inclusion complex for enhanced solubility and anti-tumor efficiency of bufalin","volume":"78","author":"Zou","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.bioorg.2025.108801_bb0640","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1186\/s11671-017-2346-8","article-title":"Improved antitumor efficacy and pharmacokinetics of Bufalin via PEGylated liposomes","volume":"12","author":"Yuan","year":"2017","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.bioorg.2025.108801_bb0655","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.2147\/DDDT.S224312","article-title":"Cinobufagin suppresses the characteristics of osteosarcoma Cancer cells by inhibiting the IL-6-OPN-STAT3 pathway","volume":"13","author":"Zhang","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2025.108801_bb0695","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.colsurfa.2019.03.060","article-title":"Dual-modified bufalin loaded liposomes for enhanced tumor targeting","volume":"571","author":"Zhang","year":"2019","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bioorg.2025.108801_bb0315","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.colsurfa.2013.12.006","article-title":"Preparation, characterization and evaluation of bufalin liposomes coated with citrus pectin","volume":"444","author":"Li","year":"2014","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bioorg.2025.108801_bb0260","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3109\/03639040903264397","article-title":"Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers","volume":"36","author":"Li","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.bioorg.2025.108801_bb0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.04.005","article-title":"The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers","volume":"393","author":"Li","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.108801_bb0580","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1166\/jbn.2019.2681","article-title":"Bufalin-loaded CaP\/DPPE-PEG-EGF Nanospheres: preparation, cellular uptake, distribution, and anti-tumor effects","volume":"15","author":"Xu","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0645","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.2147\/IJN.S139128","article-title":"Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles","volume":"12","author":"Yuan","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2025.108801_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124819","article-title":"pH-responsive bufadienolides nanocrystals decorated by chitosan quaternary ammonium salt for treating colon cancer","volume":"242","author":"Tian","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121522","article-title":"Nanocrystals with different stabilizers overcome the mucus and epithelial barriers for oral delivery of multicomponent Bufadienolides","volume":"616","author":"Tian","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.108801_bb0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2014.12.054","article-title":"A bufadienolide-loaded submicron emulsion for oral administration: stability, antitumor efficacy and toxicity","volume":"479","author":"Li","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.108801_bb0295","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/10837450.2023.2196330","article-title":"Application of a novel multicomponent nanoemulsion to tumor therapy based on the theory of \u201cunification of drugs and excipients\u201d","volume":"28","author":"Li","year":"2023","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0730","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1080\/21691401.2017.1375938","article-title":"Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability","volume":"46","author":"Zuo","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0080","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2025.108801_bb0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/IJN.S149196","article-title":"Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles","volume":"13","author":"Chen","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2025.108801_bb0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.108801_bb0370","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108801_bb0535","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev-immunol-020711-075008","article-title":"Cancer and inflammation: an old intuition with rapidly evolving new concepts","volume":"30","author":"Trinchieri","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0400","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/ijms23031328","article-title":"The apoptosis paradox in Cancer","volume":"23","author":"Morana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108801_bb0440","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1349-7006.2011.01900.x","article-title":"Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways","volume":"102","author":"Qi","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2025.108801_bb0610","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.7314\/APJCP.2012.13.11.5339","article-title":"Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients","volume":"13","author":"Yin","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bioorg.2025.108801_bb0450","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1472-6882-13-185","article-title":"Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells","volume":"13","author":"Qiu","year":"2013","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.bioorg.2025.108801_bb0050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1159\/000488842","article-title":"Cinobufagin induces apoptosis in osteosarcoma cells via the mitochondria-mediated apoptotic pathway","volume":"46","author":"Dai","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bioorg.2025.108801_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mrfmmm.2011.09.010","article-title":"Bufalin induces G0\/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells","volume":"732","author":"Huang","year":"2012","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bioorg.2025.108801_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129851","article-title":"Resibufogenin induces G1-phase arrest through the proteasomal degradation of cyclin D1 in human malignant tumor cells","volume":"10","author":"Ichikawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108801_bb0710","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3892\/etm.2022.11368","article-title":"Resibufogenin inhibits the malignant characteristics of multiple myeloma cells by blocking the PI3K\/Akt signaling pathway","volume":"24","author":"Zhou","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bioorg.2025.108801_bb0165","first-page":"114","article-title":"Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells","volume":"27","author":"Hong","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canlet.2022.01.025","article-title":"Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression","volume":"531","author":"Hou","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.108801_bb0540","doi-asserted-by":"crossref","first-page":"20193","DOI":"10.18632\/oncotarget.7935","article-title":"Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1\u03b1 via the PI3K\/AKT\/mTOR pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.108801_bb0305","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/cas.13988","article-title":"Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin\/hypoxia-inducible factor 1\u03b1 axis","volume":"110","author":"Li","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2025.108801_bb0470","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7150\/ijbs.8056","article-title":"Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress","volume":"10","author":"Shen","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bioorg.2025.108801_bb0360","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3892\/or.2016.4782","article-title":"Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS\/JNK\/p38 signaling pathway","volume":"36","author":"Ma","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0595","first-page":"158","article-title":"Inhibitory efficacy of bufadienolides on Na(+),K(+)-pump activity versus cell proliferation","volume":"6","author":"Xu","year":"2016","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0110","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1426434","article-title":"Bufalin suppresses migration and invasion of hepatocellular carcinoma cells elicited by poly (I:C) therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bioorg.2025.108801_bb0670","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70501","article-title":"Cinobufagin enhances the sensitivity of Cisplatin-resistant lung Cancer cells to chemotherapy by inhibiting the PI3K\/AKT and MAPK\/ERK pathways","volume":"29","author":"Zhang","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bioorg.2025.108801_bb0410","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12935-021-02150-0","article-title":"Cinobufagin-induced DNA damage response activates G(2)\/M checkpoint and apoptosis to cause selective cytotoxicity in cancer cells","volume":"21","author":"Niu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108801_bb0685","first-page":"618","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2021","author":"Zhang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2025.108801_bb0345","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1111\/cas.13788","article-title":"Resibufogenin suppresses transforming growth factor-\u03b2-activated kinase 1-mediated nuclear factor-\u03baB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3","volume":"109","author":"Liu","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2025.108801_bb0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/OTT.S333233","article-title":"The research Progress of Bufalin in the treatment of hepatocellular carcinoma","volume":"15","author":"Jiang","year":"2022","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bioorg.2025.108801_bb0385","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.3390\/cancers16152739","article-title":"Bufalin suppresses head and neck Cancer development by modulating immune responses and targeting the \u03b2-catenin signaling pathway","volume":"16","author":"Mhaidly","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.108801_bb0510","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10495-023-01930-5","article-title":"Mechanism of bufalin inhibition of colon cancer liver metastasis by regulating M2-type polarization of Kupffer cells induced by highly metastatic colon cancer cells","volume":"29","author":"Tang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2025.108801_bb0630","first-page":"10","article-title":"Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma","author":"Yu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioorg.2025.108801_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155395","article-title":"Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1\/\u03b2-catenin signaling","volume":"126","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2025.108801_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.008","article-title":"Bufalin targets the SRC-3\/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer","volume":"513","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.108801_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12935-018-0706-9","article-title":"Arenobufagin induces MCF-7 cell apoptosis by promoting JNK-mediated multisite phosphorylation of yes-associated protein","volume":"18","author":"Deng","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioorg.2025.108801_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144217","article-title":"Bufadienolides from the skin secretions of the Neotropical toad","volume":"26","author":"Rodriguez","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108801_bb0555","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1007\/s13277-015-4381-3","article-title":"The effects of bufadienolides on HER2 overexpressing breast cancer cells","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10495-011-0573-5","article-title":"Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3\/Mcl-1 pathway","volume":"16","author":"Dong","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2025.108801_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2019.108490","article-title":"New bufadienolides extracted from Rhinella marina inhibit Na,K-ATPase and induce apoptosis by activating caspases 3 and 9 in human breast and ovarian cancer cells","volume":"152","author":"Garcia","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.bioorg.2025.108801_bb0420","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijbiomac.2022.12.280","article-title":"Bufadienolides preferentially inhibit aminopeptidase N among mammalian metallo-aminopeptidases; relationship with effects on human melanoma MeWo cells","volume":"229","author":"Pascual Alonso","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0425","doi-asserted-by":"crossref","first-page":"25175","DOI":"10.1039\/C7RA01085K","article-title":"Cinobufagin, a bufadienolide, activates ROS-mediated pathways to trigger human lung cancer cell apoptosis in vivo","volume":"7","author":"Peng","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108801_bb0590","first-page":"158","article-title":"Inhibitory efficacy of bufadienolides on Na","volume":"6","author":"Xu","year":"2016","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cbi.2014.06.003","article-title":"Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt","volume":"219","author":"Deng","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.108801_bb0500","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/jf802769g","article-title":"Involvement of caspases and apoptosis-inducing factor in bufotalin-induced apoptosis of Hep 3B cells","volume":"57","author":"Su","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2025.108801_bb0550","article-title":"Anti-gastric cancer activity in three-dimensional tumor spheroids of bufadienolides","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2012.07.005","article-title":"Apoptotic cell death by the novel natural compound, cinobufotalin","volume":"199","author":"Emam","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.108801_bb0615","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1349-7006.2008.00966.x","article-title":"Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells","volume":"99","author":"Yu","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2025.108801_bb0430","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.toxicon.2015.11.015","article-title":"Bufadienolides from parotoid gland secretions of Cuban toad Peltophryne fustiger (Bufonidae): inhibition of human kidney Na(+)\/K(+)-ATPase activity","volume":"110","author":"Perera C\u00f3rdova","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.bioorg.2025.108801_bb0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12935-019-0806-1","article-title":"New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin","volume":"19","author":"Cheng","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioorg.2025.108801_bb0335","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.18632\/oncotarget.6840","article-title":"Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin \u03b12\/\u03b25\/FAK signaling pathway","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.108801_bb0575","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/tox.22325","article-title":"Bufalin induces apoptosis in vitro and has antitumor activity against human lung cancer xenografts in vivo","volume":"32","author":"Wu","year":"2017","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0665","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2012.06.045","article-title":"Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2\/M cell cycle arrest and apoptosis","volume":"692","author":"Zhang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0620","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1038\/s41598-018-22113-2","article-title":"Bufalin suppresses hepatocarcinogenesis by targeting \u03b2-catenin\/TCF signaling via cell cycle-related kinase","volume":"8","author":"Yu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0545","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/457193","article-title":"Bufalin inhibits HCT116 Colon Cancer cells and its Orthotopic xenograft tumor in mice model through genes related to apoptotic and PTEN\/AKT pathways","volume":"2015","author":"Wang","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.bioorg.2025.108801_bb0075","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.18632\/oncotarget.2541","article-title":"Proscillaridin a is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo","volume":"5","author":"Denicola\u00ef","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.108801_bb0625","doi-asserted-by":"crossref","first-page":"15725","DOI":"10.18632\/oncotarget.7398","article-title":"Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.108801_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116406","article-title":"Toxic profile of marinobufagin from poisonous Amazon toads and antitumoral effects on human colorectal carcinomas","volume":"310","author":"Ferreira","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0145","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s11033-011-0908-x","article-title":"Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK","volume":"39","author":"Gao","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2025.108801_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/243859","article-title":"Bufalin reverses HGF-induced resistance to EGFR-TKIs in EGFR mutant lung Cancer cells via blockage of met\/PI3k\/Akt pathway and induction of apoptosis","volume":"2013","author":"Kang","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bioorg.2025.108801_bb0160","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.2147\/OTT.S182840","article-title":"Transcatheter hepatic arterial chemoembolization plus cinobufotalin injection adjuvant therapy for advanced hepatocellular carcinoma: a meta-analysis of 27 trials involving 2,079 patients","volume":"11","author":"Guo","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bioorg.2025.108801_bb0255","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12732","article-title":"Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794","volume":"53","author":"Lan","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bioorg.2025.108801_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.778834","article-title":"Cytotoxic effects of Arsenite in combination with Gamabufotalin against human glioblastoma cell lines","volume":"11","author":"Yuan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7150\/jca.91301","article-title":"Effectiveness and safety of Chinese herbal injections combined with SOX chemotherapy regimens for advanced gastric Cancer: a Bayesian network Meta-analysis","volume":"15","author":"Bu","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108801_bb0600","doi-asserted-by":"crossref","DOI":"10.1177\/15347354241237234","article-title":"Efficacy and safety of Huachansu as an adjuvant therapy for non-small cell lung Cancer: An overview of systematic reviews and Meta-analyses","volume":"23","author":"Yang","year":"2024","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.bioorg.2025.108801_bb0135","article-title":"Unresectable hepatocellular carcinoma: transarterial chemoembolisation plus Huachansu \u2013 a single-center randomised controlled trial","author":"Gao","year":"2023","journal-title":"BMJ Support. Palliat. Care"},{"key":"10.1016\/j.bioorg.2025.108801_bb0380","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1002\/cncr.24602","article-title":"Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer","volume":"115","author":"Meng","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2025.108801_bb0390","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/03602532.2023.2206065","article-title":"Bufalin serves as a pharmaceutic that mitigates drug resistance","volume":"55","author":"Miao","year":"2023","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bioorg.2025.108801_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3736\/jcim20030311","article-title":"Clinical observation of cinobufacini injection used to treat moderate and advanced primary liver cancer","volume":"1","author":"Chen","year":"2003","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"10.1016\/j.bioorg.2025.108801_bb0445","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.3748\/wjg.14.5210","article-title":"Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma","volume":"14","author":"Qin","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0375","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/bjc.2012.283","article-title":"Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas","volume":"107","author":"Meng","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108801_bb0725","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1044027","article-title":"Bufadienolides originated from toad source and their anti-inflammatory activity","volume":"13","author":"Zou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0560","article-title":"Resibufogenin and cinobufagin activate central neurons through an ouabain-like action","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108801_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22862","article-title":"Investigation of cytotoxic effect of the bufanolide steroid compound cinobufagin and its related underlying mechanism in brain cell models","volume":"35","author":"Hsu","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0185","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s12272-011-0910-9","article-title":"Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides","volume":"34","author":"Hu","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2025.108801_bb0585","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ntt.2019.03.004","article-title":"Analgesic and toxic effects of venenum bufonis and its constituent compound cinobufagin: a comparative study","volume":"73","author":"Xu","year":"2019","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.bioorg.2025.108801_bb0005","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1515\/pac-2023-0214","article-title":"Bufotalin inhibits porcine kidney cortex aminopeptidase N and is cytotoxic to APN+ tumor cells","volume":"95","author":"Almeida Garc\u00eda","year":"2023","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.bioorg.2025.108801_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188641","article-title":"Is tumour-expressed aminopeptidase N (APN\/CD13) structurally and functionally unique?","volume":"1876","author":"Barnieh","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:39:27Z","timestamp":1757655567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":146,"alternative-id":["S0045206825006819"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108801","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bufadienolides as bioorganic anticancer agents: Mechanistic insights into apoptosis, cell cycle arrest and signal pathway modulation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108801"}}